Theravance Biopharma (NASDAQ: TBPH) announced that the U.S. Food and Drug Administration (FDA) granted Fast Track Designation to TD-8954 for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Management Comments

Theravance Biopharma (TBPH) Tops Q2 EPS by 9cAugust 10, 2015 4:22 PM Theravance Biopharma Receives FDA Fast Track Designation for TD-8954 for Use With Enteral Feeding in Critically Ill PatientsAugust 6, 2015 8:05 AM Theravance Biopharma Announces New Employment Inducement AwardsAugust 4, 2015 5:00 PM